A Phase 3b Open-label Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Cystic Fibrosis Subjects - VBX19-445-115

Clements, Barry (Chief Investigator)

UWA Medical School

Status	Finished
Effective start/end date	26/09/19 → 31/12/21

Funding

Vertex: A$3,737.00
Vertex: A$10,364.00
Vertex: A$69,213.00
Vertex: A$6,959.00
Vertex: A$32,418.00
Vertex: A$3,511.00
Vertex: A$11,069.00
Vertex: A$9,311.00
Vertex: A$4,612.00
Vertex: A$11,450.00
Vertex: A$10,547.00
Vertex: A$6,622.00
Vertex: A$5,610.00
Vertex: A$14,080.00